Left atrial mechanical function and clinical performance in non-dilated versus dilated cardiomyopathy

Özden Seçkin1, Serkan Ünlü1, Gülten Taçoy Aydoğdu1

  • 1Gazi University Hospital Cardiology Department, Ankara, Türkiye.

Postgraduate Medicine
|October 9, 2025
PubMed

Insights

Non-dilated left ventricular cardiomyopathy (NDLVC) patients show better left atrial (LA) conduit strain than dilated cardiomyopathy (DCM) patients. This LA strain is a key predictor of exercise capacity in these heart conditions.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Heart Failure Research

Background:

  • Non-dilated left ventricular cardiomyopathy (NDLVC) presents with reduced ejection fraction but normal chamber size, distinguishing it from dilated cardiomyopathy (DCM).
  • The clinical and structural characteristics of NDLVC are not fully understood, necessitating further investigation into its pathophysiology and differentiation from DCM.

Purpose of the Study:

  • To compare left atrial (LA) phasic strain parameters between NDLVC and DCM patients with similar ejection fractions.
  • To evaluate the relationship between LA function and exercise capacity, assessed by the 6-minute walk test (6MWT).

Main Methods:

  • A prospective observational study enrolled 83 patients with non-ischemic systolic dysfunction (51 NDLVC, 32 DCM).
  • Comprehensive transthoracic echocardiography with speckle-tracking imaging was used for LA strain analysis (reservoir, conduit, contractile phases).
  • Functional capacity was measured using the 6-minute walk test (6MWT).

Main Results:

  • NDLVC patients demonstrated significantly higher LA reservoir and conduit strain compared to DCM patients.
  • LA conduit strain strongly correlated with 6MWT distance (r=0.42, p=0.002).
  • LA conduit strain was identified as the sole independent predictor of functional capacity in multivariable analysis.

Conclusions:

  • Left atrial conduit strain effectively differentiates between NDLVC and DCM, reflecting distinct functional and structural profiles.
  • The strong association of LA conduit strain with exercise capacity suggests its utility in clinical assessment and follow-up for non-ischemic cardiomyopathy.
  • Preserved LA conduit function in NDLVC may indicate a less hemodynamically burdened atrium, correlating with better clinical outcomes and functional capacity.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K